BRIDGEWAY CAPITAL MANAGEMENT, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2015$107,000
-25.2%
73,5000.0%0.00%
-33.3%
Q2 2015$143,000
+7.5%
73,5000.0%0.00%0.0%
Q1 2015$133,000
+12.7%
73,500
+47.6%
0.00%0.0%
Q4 2014$118,000–49,800–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2015.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders